X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs IPCA LABS - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD IPCA LABS WYETH LTD/
IPCA LABS
 
P/E (TTM) x 27.7 41.9 66.2% View Chart
P/BV x 5.3 3.2 166.5% View Chart
Dividend Yield % 1.3 0.2 796.4%  

Financials

 WYETH LTD   IPCA LABS
EQUITY SHARE DATA
    WYETH LTD
Mar-13
IPCA LABS
Mar-17
WYETH LTD/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs1,044643 162.4%   
Low Rs818503 162.7%   
Sales per share (Unadj.) Rs298.6254.4 117.4%  
Earnings per share (Unadj.) Rs57.216.1 356.2%  
Cash flow per share (Unadj.) Rs58.429.8 196.2%  
Dividends per share (Unadj.) Rs17.001.00 1,700.0%  
Dividend yield (eoy) %1.80.2 1,045.9%  
Book value per share (Unadj.) Rs249.5194.6 128.2%  
Shares outstanding (eoy) m22.72126.20 18.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.12.3 138.5%   
Avg P/E ratio x16.335.7 45.6%  
P/CF ratio (eoy) x15.919.2 82.9%  
Price / Book Value ratio x3.72.9 126.8%  
Dividend payout %29.76.2 477.3%   
Avg Mkt Cap Rs m21,15772,300 29.3%   
No. of employees `0000.513.3 3.7%   
Total wages/salary Rs m4006,960 5.7%   
Avg. sales/employee Rs Th13,787.42,413.5 571.3%   
Avg. wages/employee Rs Th813.0523.2 155.4%   
Avg. net profit/employee Rs Th2,643.3152.4 1,733.9%   
INCOME DATA
Net Sales Rs m6,78332,106 21.1%  
Other income Rs m353226 156.2%   
Total revenues Rs m7,13632,332 22.1%   
Gross profit Rs m1,6174,448 36.4%  
Depreciation Rs m271,730 1.5%   
Interest Rs m6241 2.3%   
Profit before tax Rs m1,9382,703 71.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m632675 93.6%   
Profit after tax Rs m1,3012,028 64.1%  
Gross profit margin %23.813.9 172.1%  
Effective tax rate %32.625.0 130.6%   
Net profit margin %19.26.3 303.5%  
BALANCE SHEET DATA
Current assets Rs m6,98417,340 40.3%   
Current liabilities Rs m2,0569,559 21.5%   
Net working cap to sales %72.624.2 299.8%  
Current ratio x3.41.8 187.3%  
Inventory Days Days99100 99.0%  
Debtors Days Days2457 42.1%  
Net fixed assets Rs m24420,779 1.2%   
Share capital Rs m227252 90.0%   
"Free" reserves Rs m5,44124,499 22.2%   
Net worth Rs m5,66824,553 23.1%   
Long term debt Rs m253,517 0.7%   
Total assets Rs m7,90139,595 20.0%  
Interest coverage x353.312.2 2,890.0%   
Debt to equity ratio x00.1 3.1%  
Sales to assets ratio x0.90.8 105.9%   
Return on assets %16.55.7 288.5%  
Return on equity %22.98.3 277.8%  
Return on capital %34.010.5 324.6%  
Exports to sales %0.248.6 0.4%   
Imports to sales %36.314.2 255.3%   
Exports (fob) Rs m1515,617 0.1%   
Imports (cif) Rs m2,4654,571 53.9%   
Fx inflow Rs m1515,617 0.1%   
Fx outflow Rs m2,6775,828 45.9%   
Net fx Rs m-2,6629,790 -27.2%   
CASH FLOW
From Operations Rs m9232,764 33.4%  
From Investments Rs m317-1,432 -22.1%  
From Financial Activity Rs m-481-1,591 30.2%  
Net Cashflow Rs m759-259 -293.3%  

Share Holding

Indian Promoters % 0.0 45.9 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 11.4 99.1%  
FIIs % 7.2 25.3 28.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 17.4 174.7%  
Shareholders   21,978 36,892 59.6%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   SHASUN PHARMA  DR. REDDYS LAB  TORRENT PHARMA  UNICHEM LAB  MERCK LTD  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WYETH LTD WITH

MARKET STATS